JH-II-127
JH-II-127 is a potent, orally bioavailable small molecule inhibitor of LRRK2, demonstrating nanomolar IC50 values against wild-type (6.6 nM), G2019S (2.2 nM), and A2016T (47.7 nM) variants. This compound is a valuable research tool for investigating LRRK2 biology and its implications in Parkinson's disease through in vitro and in vivo models.
Product Specifications
CAS Number
1700693-08-8
Product Name Alternative
Ser935, 3T3 cells, parkinson's disease, LRRK2-A2016T, LRRK2-G2019S, LRRK2, Inhibitor, inhibit, JHII127, JH-II127, JH-II-127, JH-II 127, JH II 127, Leucine-rich repeat kinase 2, HEK293
Field of Research
Cell Biology
Purity
≥98% (May vary between batches)
Solubility
DMSO:30 mg/mL (71.97 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.8 mM)
Smiles
CNc1nc (Nc2ccc (cc2OC) C (=O) N2CCOCC2) nc2[nH]cc (Cl) c12
Molecular Formula
C19H21ClN6O3
Molecular Weight
416.86
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7072857 Inquire
Recombinant Vitis vinifera NAD (P)H-quinone oxidoreductase subunit 3, chloroplastic (ndhC), partial
Sign In for Pricing
View Details 
19552124 3x 1.0µg DNA
EWSR1 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details